Solutions: Clinical Trials

6 trials of Solutions, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 terminated. 6 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Terminated 6
Phase 21Terminated 1

Follow Solutions: new trials by email Literature Review of Solutions trials Research Report on Solutions

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion)
BT097 - Congenital Cytomegalovirus Infection
Phase 3TerminatedBiotest482021-11-172025-03-10
Topical Application of Cocaine HCl 4% and 10% on Safety and Efficacy in Local (Topical) Anesthesia
Cocaine HCl 4% Topical Solution, Cocaine HCl 10% Topical Solution, Placebo Topical Solution - Diagnostic, Procedures and Surgeries on or Through Accessible Mucous Membranes
Phase 3TerminatedLannett Company, Inc.1592014-03-012017-05-12
High Volume Lactated Ringer's Solution and Pancreatitis
Administration of Lactated Ringer's (LR) Solution - Pancreatitis
Phase 2 / Phase 3TerminatedEndeavor Health262014-01-012019-09-06
Phase 3 IGIV, 10% in Alzheimer´s Disease
Immune Globulin Intravenous (Human), 10% Solution, Human albumin 0.25% - Alzheimer´s Disease
Phase 3TerminatedBaxalta now part of Shire5082012-01-232021-05-19
Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)(TERMINATED)
Combination of pegylated interferon alfa-2b (PEG) and ribavirin (RBV) - Hepatitis C, Chronic
Phase 3TerminatedMerck Sharp & Dohme LLC562006-12-012017-04-07
Impact Of Antioxidant Micronutrients On Intensive Care Unit (ICU) Outcome
Selenium (Se), Zinc (Zn), Vitamin C, Vitamin B1, Vitamin E, Placebo - Critically Ill Patients, Cardiac Surgery
Phase 3TerminatedCentre Hospitalier Universitaire Vaudois2002003-01-012010-07-30

Conditions studied

Critical Illness (1)  ·  Cytomegalovirus Infections (1)  ·  Disease (1)  ·  Hepatitis C, Chronic (1)  ·  Pancreatitis (1)  ·  Subarachnoid Hemorrhage (1)  ·  Wounds and Injuries (1)

Sponsors

Baxalta now part of Shire (1)  ·  Biotest (1)  ·  Centre Hospitalier Universitaire Vaudois (1)  ·  Endeavor Health (1)  ·  Lannett Company, Inc. (1)  ·  Merck Sharp & Dohme LLC (1)

Countries

United States (3)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  Germany (1)  ·  Japan (1)  ·  Poland (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Karl O Kagan, Prof (1)  ·  Mette M Berger, MD PhD (1)  ·  Mick Meiselman, MD (1)  ·  Russell Brown, MD (1)  ·  Zachary Smith, MD (1)

Results publications

PMID 18687132, PMID 33879722